HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen-Ter Lai Selected Research

Sodium-Glucose Transporter 2

2/2022Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension.
6/2021Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin.
8/2020Effects of Secretome from Fat Tissues on Ion Currents of Cardiomyocyte Modulated by Sodium-Glucose Transporter 2 Inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen-Ter Lai Research Topics

Disease

15Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 01/2004
13Hypertension (High Blood Pressure)
02/2022 - 06/2004
13Stroke (Strokes)
02/2022 - 11/2005
13Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 01/2004
13Myocardial Infarction
02/2022 - 05/2004
9Atrial Fibrillation
02/2022 - 03/2011
9Hemorrhage
07/2017 - 12/2004
8Acute Coronary Syndrome
01/2019 - 03/2006
7Thrombosis (Thrombus)
01/2019 - 04/2003
6Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2020 - 01/2013
6Hyperlipidemias (Hyperlipidemia)
01/2018 - 01/2004
6Ischemic Stroke
01/2018 - 12/2012
5Heart Failure
02/2022 - 01/2013
5Cardiac Arrhythmias (Arrythmia)
02/2022 - 03/2005
5Essential Hypertension
01/2022 - 01/2005
5Chronic Renal Insufficiency
01/2019 - 01/2013
5Body Weight (Weight, Body)
11/2015 - 02/2007
5Fibrosis (Cirrhosis)
05/2013 - 11/2007
5Hypercholesterolemia
05/2012 - 02/2005
4Type 2 Diabetes Mellitus (MODY)
02/2022 - 03/2006
4Diabetes Mellitus
01/2020 - 06/2004
4Inflammation (Inflammations)
12/2017 - 03/2006
3ST Elevation Myocardial Infarction
11/2013 - 12/2004
3Atherosclerosis
01/2013 - 06/2006
3Ventricular Tachycardia
12/2009 - 02/2007
3Chest Pain (Chest Pains)
07/2007 - 05/2004
3Heart Diseases (Heart Disease)
05/2007 - 01/2004
2Cardiac Sudden Death (Sudden Cardiac Arrest)
02/2022 - 05/2007
2Hypotension (Low Blood Pressure)
01/2018 - 03/2005
2Coronary Disease (Coronary Heart Disease)
05/2017 - 05/2016
2Dyslipidemias (Dyslipidemia)
11/2015 - 06/2006
2Non-ST Elevated Myocardial Infarction
11/2014 - 06/2010
2Stable Angina
11/2014 - 04/2006
2Chronic Kidney Failure (Chronic Renal Failure)
11/2014 - 07/2014
2Peripheral Arterial Disease
08/2013 - 01/2013
2Rupture
05/2013 - 10/2009
2Hyperkalemia
01/2012 - 03/2005
2Tachycardia (Tachyarrhythmias)
12/2009 - 09/2004
2Endocarditis
09/2008 - 01/2007
2Atrial Remodeling
12/2007 - 09/2007
2Shock
09/2006 - 02/2005
2Infections
02/2005 - 06/2002
2Infarction (Infarctions)
05/2004 - 03/2004
1Chronic Hepatitis C
11/2020
1Mitral Valve Insufficiency (Mitral Regurgitation)
11/2018

Drug/Important Bio-Agent (IBA)

10Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019 - 01/2004
9LipidsIBA
11/2020 - 06/2002
7Clopidogrel (Plavix)FDA Link
01/2019 - 06/2010
7Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2014 - 06/2010
6Glucose (Dextrose)FDA LinkGeneric
02/2022 - 05/2007
6Atorvastatin (Lipitor)FDA Link
01/2013 - 01/2004
5oxidized low density lipoproteinIBA
01/2018 - 11/2013
5C-Reactive ProteinIBA
03/2015 - 01/2004
4Biomarkers (Surrogate Marker)IBA
01/2018 - 03/2006
4omega-Chloroacetophenone (Mace)IBA
07/2017 - 01/2013
3Sodium-Glucose Transporter 2 InhibitorsIBA
02/2022 - 08/2020
3Sodium-Glucose Transporter 2IBA
02/2022 - 08/2020
3AdiponectinIBA
03/2019 - 03/2006
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2019 - 07/2014
3Anti-Bacterial Agents (Antibiotics)IBA
11/2018 - 01/2007
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2017 - 09/2004
3Pharmaceutical PreparationsIBA
09/2015 - 01/2005
3Proteins (Proteins, Gene)FDA Link
01/2015 - 11/2014
3Warfarin (Coumadin)FDA LinkGeneric
09/2013 - 03/2011
3Matrix Metalloproteinases (MMPs)IBA
05/2013 - 11/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2010 - 12/2005
3Antihypertensive Agents (Antihypertensives)IBA
04/2006 - 01/2005
2empagliflozinIBA
06/2021 - 08/2020
2lercanidipineIBA
01/2017 - 04/2006
2Estradiol (Delestrogen)FDA LinkGeneric
04/2016 - 01/2013
2ReninIBA
12/2015 - 10/2014
2CholesterolIBA
11/2015 - 05/2012
2Hemoglobins (Hemoglobin)IBA
01/2015 - 06/2010
2Cilostazol (Pletal)FDA LinkGeneric
08/2013 - 01/2013
2olmesartanIBA
05/2013 - 01/2005
2Amlodipine (Norvasc)FDA LinkGeneric
05/2013 - 06/2008
2Indicators and Reagents (Reagents)IBA
11/2011 - 07/2007
2Verapamil (Calan)FDA LinkGeneric
12/2007 - 09/2007
2Losartan (Cozaar)FDA LinkGeneric
04/2006 - 01/2005
2Dihydrotachysterol (AT 10)IBA
03/2006 - 01/2006
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2005 - 01/2005
2Oxygen (Dioxygen)IBA
02/2005 - 01/2005
1azilsartan medoxomilIBA
01/2022
1Carvedilol (Coreg)FDA LinkGeneric
03/2021
1Antiviral Agents (Antivirals)IBA
11/2020
1RNA (Ribonucleic Acid)IBA
11/2020
1Glyburide (Glibenclamide)FDA LinkGeneric
08/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
07/2020
1Anti-Arrhythmia AgentsIBA
01/2020
1AlbuminsIBA
01/2020
1DronedaroneFDA Link
01/2020
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2019

Therapy/Procedure

22Therapeutics
02/2022 - 01/2004
7Percutaneous Coronary Intervention
01/2019 - 02/2005
6Catheter Ablation
04/2017 - 02/2007
5Stents
01/2019 - 04/2003
3Renal Dialysis (Hemodialysis)
01/2012 - 03/2005
2Secondary Prevention
01/2019 - 01/2013
2Drug-Eluting Stents
11/2014 - 11/2014
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2019